G20
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Bilateral Implantation of electrodes for deep brain stimulation of the subthalamic nucleus for the treatment of idiopathic Parkinson's disease: a. at least 3 months prior to study participation b. the implanted pulse generator enables a pulse width of 30µs per clinical routine (Boston Scientific Vercise, Vercise PC and Gevia; Abbott Medical Infinity DBS System 2. The patient is not allowed to participate at another studies during which an adjustment of medication or stimulation parameters is needed at the same time 3. Patients need to agree with video and voice recordings and sign a patient consent form
Exclusion criteria
Exclusion criteria: Inclusion criteria not completed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Motor Diary during the last three days before the next follow-up visit after 4 weeks of deep brain stimulation with one of the two pulse widths (30µs or 60µs) - co-primary endpoint: Unified Parkinson's disease rating scale in MedOFF/StimON at follow-up visit | — |
Secondary
| Measure | Time frame |
|---|---|
| After four weeks of deep brain stimulation with one of the two pulse widths respectively (30µs or 60µs): - energy consumption - Parkinson's disease Questionnaire 39 - Non-motor symptom scale, Non-motor symptoms questionnaire - reading of a German standard text additionally: - preferred setting after finishing the study | — |
Countries
Germany
Contacts
Universitätskliniken Köln Klinik und Poliklinik für Neurologie